InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TPST stock results show that Tempest Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
The post TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace